Daily Stock List
DoMark International, Inc. (DOMK)
smartOTC reported today on DoMark International, Inc. (DOMK), The Global Investment Group, Your Stock Alert, The Stock Brainiac, Pumps and Dumps, Real Pennies, StockHideout, PennyTrader Publisher did earlier, and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Longwood, Florida, DoMark International, Inc. is a marketing and management company. They engage in owning, developing, and marketing an assortment of patented innovative consumer products via their wholly owned subsidiaries, SolaWerks, Inc. and Musclefoot, Inc. Incorporated in 2006 in the state of Nevada, DoMark International lists on the OTC Markets' OTCQB.
The Company researches, evaluates, and acquires profitable private firms in the business segments of sports, technology, medical, energy, and business services. They provide the financial and human capital that these businesses require.
The Company's SolaWerks is dedicated to revolutionizing the efficiency and capabilities of a new generation of mobile devices. Their mission is to become a leader in the emerging mobile device accessories market. The current focus of DoMark's SolaWerks is to develop and distribute the SolaPad, a combined cover and charging system for Apple's iPad, and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone.
DoMark International's Musclefoot subsidiary distributes, markets, and acts as sales agent for the patented foot care system, Barefoot Science.
For the quarter ended August 31, 2012, DoMark International had $20,345 in total revenues. Revenues earned for the period were related to sales via their wholly owned subsidiaries Solawerks, $15,752, and Musclefoot, $4,593. Licensing fees increased by $394,520. The operating loss for the quarter amounted to ($1,186,799) or a Net loss per share of $0.04 versus a Net loss per share of $0.00 for the same 3 month period in 2011.
Yesterday, DoMark International's SolaWerks subsidiary announced in conjunction with the release of Apple's iPhone 5 and iPad Mini, the implementation of new smart device technology that will significantly improve usability. This technology will first be released for use with the iPhone 4/4s, followed shortly after with a release for the iPhone 5.
This innovative technology more than doubles the average usage time for these devices. DoMark expects to start accepting pre-orders immediately following the launch. In addition, DoMark is incorporating this newly developed technology for Amazon's Fire, Google's Galaxy Nexus and others.
DoMark International, Inc. (DOMK), closed Thursday's session at $0.42, off by 2.33%, on 67,597 volume with 22 trades. The average volume for the last 60 days is 68,527 and the stock's 52-week low/high is $0.32/$4.88.
Community Shores Bank Corp. (CSHB)
SmallCapInvestor.com reported previously on Community Shores Bank Corp. (CSHB), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Community Shores Bank Corp. operates as the holding company and 100 percent owner of Community Shores Bank. The Bank provides commercial and consumer banking services primarily in the communities of Muskegon County and Northern Ottawa County, Michigan. Opening for business in January 1999, Community Shores Bank has their headquarters in Muskegon, Michigan. The Bank's shares trade on the OTCQB.
Community Shores Bank's services include checking and savings accounts, certificates of deposit, safe deposit boxes, courier service and loans for commercial, mortgage and consumer purposes. The Bank offers a wide array of deposit services. These include checking accounts, savings accounts and time deposits of diverse types.
The bank tailors transaction accounts and time certificates to the principal market area. The Bank solicits these accounts from individuals, businesses, schools, associations, churches, non-profit organizations, financial institutions, as well as government authorities.
For Business Banking - Savings, the Bank offers Business Savings, Business Money Market, Certificates of Deposit, and Premium Business Money Market. For Business Banking – Loans, they offer Small Business Lines Of Credit, Term Loans, Commercial Real Estate Loans, Letters of Credit, SBA Loans, and Credit Cards.
Concerning Business Banking – Checking, Community Shores Bank offers Business Checking, Premium Small Business Checking, and Premium Business Checking with Investment Sweep, Business Interest Checking, Business Money Market, and Premium Business Money Market.
Other Business Services include Automated Clearing House (ACH) Origination. This is a low-cost, electronic funds transfer network governed by the National Automated Clearing House Association (NACHA). Businesses utilize this as a safe and secure method to process a number of transactions to help them manage their cash more efficiently. The Bank also offers Lockbox Service, Telephone Banking, Visa Business Check Card, and Business Online banking as well as a Merchant Services program. Community Shores Bank has partnered with TermNet Merchant Services to offer their customers this merchant service program.
Community Shores Bank Corp. (CSHB), closed Thursday's trading session at $0.22, even for the day. The average volume for the last 60 days is 475 and the stock's 52-week low/high is $0.05/$0.85.
Salamon Group, Inc. (SLMU)
OTC Gold Media, Alternative Energy, InvestmentDailyNews, RockingPennyStocks, FeedBlitz, BUYINS.NET, SmallCapSociety, and InvestmentDailyNews reported earlier on Salamon Group, Inc. (SLMU), and we highlight the Company, here at the QualityStocks Daily Newsletter.
By way of their Sunlogics Power Fund Management, Inc. division, Salamon Group, Inc. is a solar and renewable energy company. On May 12, 2011, Salamon Group completed the acquisition of Sunlogics Power Fund Management. Salamon Group specializes in the acquisition, construction and management of renewable energy power projects and companies. Salamon Group is based in Kelowna, British Columbia.
The Company's Sunlogics Power also looks to acquire assets and other companies in the solar and renewable energy space that are a strategic fit. Sunlogics Power is also a project-acquiring partner of Sunlogics Plc and their Subsidiary as well as other third party project developers. Sunlogics Power Fund concentrates on the acquisition of solar powered electricity generating facilities that have long term power purchasing agreements in place with local power utilities and commercial users.
On March 2, 2012, Salamon Group completed the acquisition of the Systems Business and certain Silicon technology from Arise Technologies Corp. On March 16, 2012, the Company entered into an agreement to purchase 100 percent of the issued shares of ECO Energy Solutions Australia. On March 30, 2012, they executed an MOU and Binding Letter of Intent (LOI) to acquire Solar Samoa Ltd. On April 25, 2012, Salamon Group entered into an asset purchase agreement with Avatar Solar, Inc. to acquire certain assets for consideration of $663,000 and $165,000 in a note payable.
Concerning their investment objectives, Salamon Group established a fund to invest in Sunlogics' commercial solar power installations in North America. Projects will range in size from 10Kw to 50MW plus. Sunlogics is the developer and operator of the solar installations and a vertically integrated international company. They specialize in the design, development and operation of solar energy solutions. These include rooftop, ground mount and canopy installations.
In October 2012, Salamon Group announced that their Chief Executive Officer and other certain investors increased shareholdings of the Company's common stock by acquiring 3,904,000 shares. These purchases are for investment holdings; purchases were not from treasury stock. These newly acquired share ownership positions represents 9.76 percent of Salamon Group's already issued common shares outstanding.
Salamon Group, Inc. (SLMU), closed Thursday's trading session at $0.04, up 66.67%, on 11,000 volume with 2 trades. The average volume for the last 60 days is 110,040 and the stock's 52-week low/high is $0.015/$1.10.
XRS Corp. (XRSC)
We are highlighting XRS Corp. (XRSC), here at the QualityStocks Daily Newsletter.
Listed on the NASDAQ Capital Market, XRS Corp. provides intuitive, automated fleet management software solutions to the commercial trucking industry. The Company also offers a portfolio of professional services, including implementation, training and consulting. XRS' solutions increase the productivity of approximately 114,000 trucks across North America. On August 13, 2012, Xata Corp. became XRS Corp. The Company has their headquarters in Eden Prairie, Minnesota.
XRS delivers real-time critical information on vehicle and driver performance. The Company makes it easy for fleet managers, dispatchers and drivers to collect, sort, view and analyze data. This is to assist in reducing costs, to increase safety and compliance, and to improve customer satisfaction.
The Company's award-winning solutions include XataNet. This full featured, enterprise-wide solution helps private and for-hire fleets drive continuous improvement. Their solutions also include Turnpike. This technologically advanced, low-cost, easy-to-install solution runs on drivers' existing cell phones, smartphones and tablet computers. Both of these solutions help fleet managers and drivers meet established Electronic Onboard Recorder (EOBR) regulations.
XRS' flagship applications - XataNet and Turnpike - give their customers affordable anytime, anywhere access to real-time driver and vehicle data. This includes Hours of Service, delivery times, fuel tax, idle time, location, MPG, and routes, as well as vehicle speed. The Company offers their applications through a monthly subscription service. Concerning Hours of Service, FMCSA regulations limit a driver's on-duty hours in an effort to prevent fatigue-related crashes. For example, CMV drivers transporting cargo may drive a maximum of 11 hours after 10 consecutive off-duty hours.
Today, XRS reported revenue of $15.0 million for their fiscal fourth quarter ended September 30, 2012. This is in comparison to $15.3 million for the comparable period in 2011. Net loss to common shareholders for the fourth quarter of fiscal 2012 was $0.3 million, or $0.03 per diluted share, compared to $1.6 million, or $0.15 per diluted share, for the comparable period in fiscal 2011.
The fiscal 2012 fourth quarter total gross margin of 59 percent improved 7 percentage points compared to the same period in fiscal 2011. XRS' bottom-line improvement resulted from software revenue growth of 5 percent and benefits realized from the recent business realignment that the Company earlier announced in the third quarter.
XRS Corp. (XRSC), closed today at $0.73, up 5.80%, on 600 volume with 3 trades. The average volume for the last 60 days is 6,745 and the stock's 52-week low/high is $0.49/$1.63.
Brick Brewing Co. Ltd. (BRB.TO)
Today we are reporting on Brick Brewing Co. Ltd. (BRB.TO), here at the QualityStocks Daily Newsletter.
Founded in 1984, and listed on the Toronto Stock Exchange, Brick Brewing Co. Ltd. is the Province of Ontario's largest Canadian-owned and Canadian-based publicly held brewery. The Company is a regional brewer of award-winning premium quality and value beers. Brick Brewing has official certification under the British Retail Consortium (BRC) Global Standards for Food Safety, one of the highest and most internationally recognized standards for safe food production. Brick Brewing has their corporate headquarters in Kitchener, Ontario.
The Company was the first craft brewery to start up in Ontario. On December 18, 1984, the Company's first beer rolled of the bottling line. In that first year of operation, with 10 employees, Brick Brewing produced 35,000 cases of beer.
Brick Brewing is credited with pioneering the present day craft brewing renaissance in Canada. The Company has complemented their Waterloo brand premium craft beers with additional brands. These include Laker, Red Baron, Red Cap, as well as Formosa Springs Draft.
In March 2011, Brick purchased the Canadian rights to Seagram Coolers. Brick now produces, sells, markets and distributes Seagram Coolers across Canada. This year, Brick Brewing announced the launch of three new Seagram brands. These go by the names 2012, Cider and Iced Lemon Tea.
In 2012, Net revenues for Brick Brewing increased by $0.4 million in Q4, and $4.0 million by year-end. EBITDA of $0.6 million in Q4 and $3.8 million at year-end were earned. Growth of the Company's beer brands of 11.9 percent outpaced the industry which declined by 2 percent. Brick Brewing distributes packaged beer mainly through "The Beer Store" and the "Liquor Control Board of Ontario"; licensed establishments, such as bars and restaurants; and provincial liquor boards.
In September 2012, Brick Brewing released their financial results for the second quarter ended July 29, 2012 for their fiscal year 2013. Financial highlights include Net revenues for the second quarter of fiscal 2013 of $11.5 million compared to $10.7 million in the second quarter of fiscal 2012.
Gross profit percentage for the quarter increased to 33.2 percent from 27.7 percent in the prior year comparable quarter. EBITDA for the second quarter ended July 29, 2012 was $2.3 million compared to EBITDA in the second quarter of fiscal 2012 of $1.8 million.
Brick Brewing Co. Ltd. (BRB.TO), closed Thursday at $1.53, up 9.29%, on 25,150 volume. The stock's 52-week low/high is $1.00/$1.75.
Ballard Power Systems, Inc. (BLD.TO)
We are highlighting Ballard Power Systems, Inc. (BLD.TO) today, here at the QualityStocks Daily Newsletter.
Listed on the Toronto Stock Exchange, Ballard Power Systems, Inc. is a world leader in PEM (proton exchange membrane) fuel cell technology. The Company provides clean energy fuel cell products that enable optimized power systems for a spectrum of applications. Ballard has designed and shipped almost 150 MW of hydrogen fuel cell technology to date. Founded in 1979, Ballard Power Systems is based in British Columbia, Canada.
The Company started developing fuel cells in 1983. Over time, they entered into several strategic alliances related to fuel cell research and development (R&D). They undertook a significant corporate transformation from 2007 to 2009. The Company's strategic focus shifted from long-term, high cost automotive fuel cell R&D technology development to clean energy fuel cell products for near-term commercial markets.
Concerning power generating solutions, Ballard Power Systems' ElectraGen™ fuel cell systems, fuelled by direct hydrogen or by methanol, offer significant financial and environmental advantages compared to lead acid battery and diesel generator alternatives. Ballard works with several partners to distribute and support their products. These include Dantherm Power (Ballard Power Systems holds controlling interest in Dantherm Power) headquartered in Europe, Cascadiant in Asia, Inala Technologies in South Africa and Precision Power & Air in the Caribbean.
Through these partners, the Company delivers complete fuel cell power generation solutions directly to network and service providers including Nokia Siemens, Motorola, Deutsche Telecom, Wind Mobile and Vodacom. In addition, Ballard supplies FCgen®-1020ACS fuel cell stacks to third-party system integrators working in the backup power market.
The Company also manufactures Material Products. Their material products division is a leading provider of gas diffusion layer (GDL) material and carbon friction materials. Ballard Power Systems is the only major producer of GDL material in the North American market. This material is a core fuel cell component. Moreover, the Company is also a Tier 1 supplier of carbon friction material to the automotive industry. Ballard provides innovative rollable carbon fabrics, paper and nonwovens with carefully engineered properties to match customer needs. All of the Company's material products undergo development and manufacturing at their Lowell, Massachusetts facility.
Today, Ballard Power Systems announced successful completion of the first phase of work, and significant progress on the second phase, with Anglo American Platinum under a Product Development Agreement related to fuel cell-powered electric generators for the African rural home market.
Under the agreement, Anglo American Platinum has committed to fund development and testing of the planned home generator product. It will be capable of providing primary power to homes in remote African communities that are without access to the electrical grid. Work so far has included a market feasibility study, testing of a proof-of-concept system based on existing technology from Ballard and Dantherm Power, Ballard's backup power company, and initial work on a prototype system.
Ballard Power Systems, Inc. (BLD.TO), closed Thursday's trading at $0.71, up 1.43%, on 42,252 volume. The stock's 52-week low/high is $0.67/$1.74.
Kraig Biocraft Laboratories, Inc. (KBLB)
PennyTrader Publisher, TradingAuthority Daily, and Penny Sleuth reported earlier on Kraig Biocraft Laboratories, Inc.(KBLB), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Kraig Biocraft Laboratories, Inc. engages in the development of recombinant technologies and recombinant fibers for the worldwide textile and technical textile markets. Founded in 2006, the Company focuses on the development and commercialization of commercially significant high performance polymers and technical fiber. Kraig Biocraft has successfully developed and produced next generation polymers and protein-based fibers including recombinant spider silk. This is based on proprietary genetic engineering technology. The Company's shares trade on the OTCQB and their corporate headquarters are in Lansing, Michigan.
Kraig Biocraft Laboratories works in cooperation with leading universities in the fields of genetics and genetic engineering to develop new recombinant fibers and materials. On April 12, 2011, the Company announced a landmark deal with biotechnology giant Sigma-Aldrich. On November 3, 2011, they announced a second landmark with the signing of a commercial Spider Silk licensing agreement with the University of Notre Dame. With this, the University became a Kraig shareholder.
On November 14, 2011, Kraig Biocraft announced the success of their microinjections of Sigma-Aldrich's zinc finger technology, and the creation of seven new strains of ZF transgenics. On January 5, 2012, the Company announced that the National Academy of Sciences published the peer-reviewed scientific article describing Kraig Biocraft's spider silk innovation in the prestigious journal Proceedings of the National Academy of Sciences.
Spider Silk is among the strongest fibers produced in nature. Some spider species are capable of producing up to seven different types of silk. Drag line silk (silk used when a spider is repelling) is of specific commercial interest. This natural polymer is extremely strong and extremely flexible. Kraig has obtained the exclusive right, in their field of research, for the spider silk gene sequences that are at the core of the Company's technology. Dr. Lewis of the University of Wyoming first studied and subsequently patented these genetic sequences. Kraig Biocraft Laboratories obtained certain exclusive rights in early 2006 from the University to use the sequences in their field of use.
The Company reported in August of this year that during the next twelve months, they expect to spend approximately $100,000 per quarter on collaborative research and development of high strength polymers. They also expect to spend approximately $13,700 on collaborative research and development of high strength polymers and spider silk protein at the University of Wyoming over the next twelve months.
Additionally, Kraig Biocraft will actively consider pursuing collaborative research opportunities with other university laboratories in the area of high strength polymers. They will also consider buying an established revenue producing company that is operating in a compatible arena, and they will actively consider pursuing collaborative research opportunities with private and university laboratories in areas of research that overlap the Company's existing research and development. Furthermore, they plan to pursue collaborative product manufacturing and marketing opportunities for their Monster Silk™ product with companies in the textile and related industries.
Kraig Biocraft Laboratories, Inc. (KBLB), closed Thursday's trading session at $0.0411, even for the day, on 169,400 volume with 11 trades. The average volume for the last 60 days is 203,235 and the stock's 52-week low/high is $0.0305/$0.12.
RegeneRx Biopharmaceuticals, Inc. (RGRX)
SmarTrend Newsletters reported previously on RegeneRx Biopharmaceuticals, Inc.(RGRX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company whose shares trade on the OTC Markets - OTCQB. The Company's focus is on tissue protection, repair, and regeneration with a broad portfolio of product candidates for first-in-class therapeutic peptides. RegeneRx's mission is to research and develop novel pharmaceuticals that protect and repair tissue and organ damage caused by disease, trauma or other pathology. The Company has their corporate headquarters in Rockville, Maryland.
In 1999, the Company acquired the rights to a novel peptide from the National Institutes of Health (NIH). This intellectual property for Thymosin Beta 4 (Tβ4) allowed RegeneRx to direct their focus on tissue protection and repair in multiple disease indications.
Thymosin Beta 4 is a naturally occurring peptide. It is found in high concentrations in blood platelets, wound fluid, as well as other tissues in the body. Tβ4 is not a growth factor; it is a major actin regulating peptide. Tβ4 has been found to play a vital role in the protection, regeneration, and remodeling of injured or damaged tissues. The gene for Tβ4 has also been found to be one of the first to be upregulated after a wound occurs.
RegeneRx Biopharmaceuticals is focusing on moving three distinct Tβ4-based drug candidates through the clinic. These three are RGN-137, RGN-259 and RGN-352. In addition, RegeneRx holds more than 60 issued patents or filed patent applications globally to enable and protect multiple indications and applications for their product candidates.
RegeneRx is developing, in addition to Tβ4, Tβ4 peptide fragments for cosmeceutical applications. This is separate and distinct from the pharmaceutical peptide and formulations. The Company's intention is to go after strategic business relationships to develop these smaller peptides for the cosmeceutical market.
On Monday, RegeneRx Biopharmaceuticals announced that they received a Notice of Allowance of a U.S. patent for the use of Thymosin beta 4 (Tβ4), certain fragments, isoforms, derivatives and analogues to treat patients with glaucoma and elevated intraocular pressure (IOP). The patent will expire in 2026.
RegeneRx Biopharmaceuticals, Inc. (RGRX), closed Thursday's trading session at $0.11, down 3.51%, on 31,300 volume with 5 trades. The average volume for the last 60 days is 35,113 and the stock's 52-week low/high is $0.07/$0.28.
DoMark International, Inc. (DOMK)
The QualityStocks Daily Newsletter would like to spotlight DoMark International, Inc. (DOMK). Today, DoMark International, Inc. closed trading at $0.42, off by 2.33%, on 67,597 volume with 22 trades. The stock’s average daily volume over the past 60 days is 68,527, and its 52-week low/high is $0.32/$4.88.
DoMark International, Inc. subsidiary, SolaWerks Inc. reported the implementation of new smart device technology recently, in conjunction the iPhone 5 and iPad Mini release by Apple, which is designed to vastly improve overall usability and extend run time. Set to drop for the iPhone 4 platform first (and soon thereafter iPhone 5), technology like the SolaPad combined cover and charging system comes in time to pre-order for the holiday season. The company is doing a parallel roll out on the Amazon Fire, Google Galaxy Nexus, and other platforms to keep pace with burgeoning demand in the smart phone and tablet space.
DoMark International, Inc. (DOMK) is focused on researching, evaluating, and acquiring profitable private firms in the business segments of sports, technology, medical, energy, and business services. By providing the financial and human capital necessary to deal with overwhelming administrative, planning, governance, compliance, and regulatory challenges, its newly acquired partners can focus their energy and flourish.
Through its wholly owned subsidiary, SolaWerks, Inc., DoMark is committed to revolutionizing the efficiency and capabilities of a new generation of mobile devices. The subsidiary's current focus is on developing and distributing the SolaPad, a combined cover and charging system for Apple's iPad, and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone.
Musclefoot, Inc., another wholly owned subsidiary of DoMark, is engaged in the distribution, marketing, and sale of Barefoot Science, the revolutionary patented foot care system designed to relieve foot and back pain as well as improve athletic performance. With a strong commitment to customer service and security, DoMark plans to expand its marketing relationships across a far broader product set.
The management team has positioned the company to capitalize on emerging opportunities by working with the world's most forward-thinking companies to develop and market game-changing products with the promise of long-term financial growth. Leveraging the expertise of its team, the company continues to evaluate acquisition candidates and products targeting underserved markets to increase its growth potential. Disclaimer
DoMark International, Inc. Blog
DoMark International, Inc. News:
DoMark Subsidiary SolaWerks Next Generation Technology Slated for Release
SolaWerks Next Generation Technology Slated for Release
Hot on the Heels of the Freshly Launched Apple Mini Tablet, SolaWerks Prepares to Unveil the Ultimate Apple Accessory - the Latest SolaCase
Loans4Less.com, Inc. (LFLS)
The QualityStocks Daily Newsletter would like to spotlight Loans4Less.com, Inc. (LFLS). Today, Loans4Less.com, Inc. closed trading at $0.09, up 34.33%, on 20,750 volume with 2 trades. The stock’s average daily volume over the past 60 days is 8,737, and its 52-week low/high is $0.01/$0.51.
Loans4Less.com, Inc. reported Q3 2012 financials today, showing some excellent movement in total year-over-year revenues for the quarter (up 56%) and net income (up 437%), with cash and liquid investments also up handsomely to $72.5k (up 806% from the same date in 2011). This marked increase was attributed largely to the company's swelling online presence and access to exceptionally low mortgage rates. The company also managed to reduce total liabilities over the same interval by roughly 61% to $79.4k. Chairman and President of LFLS, Steven M. Hershman, projecting a favorable market outlook for the foreseeable future, noted the significance of mounting activity in the mortgage origination market despite stringent lender underwriting standards.
Loans4Less.com, Inc. (LFLS) is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public.
Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company's expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing, and/or third party agreements that build national recognition of the Loans4Less® brand.
The management team has accumulated many years of experience in the real estate and financial services sectors. This combination of expertise provides the knowledge and foresight necessary to get the best results for the company and their thousands of loyal clients. The team skillfully navigated through the credit crisis that destroyed much of their competition, putting the company in a stronger position to increase market share.
Loans4Less.com is not exposed to the risks and/or problems that are associated with sub-prime lending. Having never defaulting on an obligation or been involved in any litigation, the company is poised for rapid growth in today's low interest rate environment with its industry leading reputation and well established relationships with respected lenders. Disclaimer
Loans4Less.com, Inc. Company Blog
Loans4Less.com, Inc. News:
Loans4Less.com Provides Preliminary Financial Results for the Third Quarter of 2012
Loans4Less.com, Inc. New Audio Interview With Chairman and CEO Steven M. Hershman
Loans4Less.com, Inc. Reports Financial Results for the Third Quarter of 2012
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $7.10, up 29.09%, on 65,141 volume with 108 trades. The stock’s average daily volume over the past 60 days is 43,015, and its 52-week low/high is $0.72/$10.01.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
TNI BioTech Inc., and Hubei Qianjiang Pharmaceuticals Co., Ltd., Announce Venture Partnership for the Development of New Drug for Cancer Therapies
Dr. Henry "Skip" Lenz, Pharm.D, Joins TNI BioTech, Inc., as Quality Control Officer
TNI BioTech Signs Agreement With Government of Malawi to Open an Oncology & Infectious Disease Clinic at Queen Elizabeth Central Hospital
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.23, off by 0.04%, on 96,421 volume with 32 trades. The stock’s average daily volume over the past 60 days is 107,911, and its 52-week low/high is $0.21/$0.69.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation to Host Third Quarter 2012 Financial Results Conference Call at 11:00 a.m. ET on Friday, November 9, 2012
International Stem Cell Corp's Lifeline Cell Technology Products to Be Added to Fisher Scientific's Catalogs
International Stem Cell Corp Discusses Its New Cellular Reprogramming Technology in View of the Recent Award of the Nobel Prize in Physiology or Medicine
Today, Loans4Less.com announced selected financial results for the third quarter ending Sept. 30, 2012. The quarterly report is available in its entirety on the OTC Markets Web site.
Total third quarter 2012 revenues for the company showed an increase of around 56 percent compared to the third quarter of 2011. The company’s third quarter net income showed an increase of 437 percent as compared with the same quarter of the previous year. This substantial improvement is related to greater consumer awareness of Loans4Less.com’s online services as well as exceptionally low national mortgage rates.
As of Sept. 30, Loans4Less.com had cash and liquid investments totaling $72.5K, which is an increase of approximately 806 percent over the previous year. The company’s total liabilities decreased from around $206.6K to $79.4K, which represents a decrease of around 61 percent.
Despite the current reality that lender underwriting standards allow only best credit quality borrowers to close on their loans, the mortgage origination market is nonetheless expected to stay very active for the remainder of this year. Currently, the mortgage market primarily consists of Fannie Mae/Freddie Mac Conforming fixed rate refinancing loans.
With mortgage rates at record lows, purchase and refinancing activity continues to rise. It is anticipated that highly favorable market conditions will continue facilitating substantial ongoing improvement as Loans4Less.com continues driving business growth and planning initiatives for future expansion. Loans4Less.com is currently interviewing CPA firms with the aim of attaining audited financial statements in the first quarter of 2013 to position itself to be placed in a Recognized Manual and be able to raise capital at favorable terms for growth initiatives.
Loans4Less.com is a publicly traded online mortgage loan brokerage. The company’s aim is to become a national loan origination platform for standard “A” paper conforming residential mortgage programs. Loans4Less.com continues to be an A+ TrustLink rated company with the Better Business Bureau and provides highly competitive rates, terms and costs; daily rate updates; and other market information.
The company prides itself on service that is exceptional and honest. Loans4Less.com does not operate a warehouse line of credit, hold trust funds, lend directly or service loans, and Loans4Less.com is not exposed to the risks and/or problems associated with sub-prime or alt “A” lending. The company relies on various wholesale lenders for its retail home loan programs, and the main focus of Loans4Less.com is to rapidly grow gross revenues through smart and cost-effective advertising, licensing, and/or third party agreements that effectively build the company’s brand name in order to maximize shareholder values.
For more information, visit www.Loans4Less.com
Mer Telemanagement Solutions announced its financial results for 3Q 2012. MTS is a global provider of MVNE services and telecommunications expense management (TEM) services and solutions.
“Our third quarter results represent continued improvements in our financial results and indicators as a result of our efforts to develop our Mobile Virtual Network Enabler (MVNE) activity and the Telecom Expense Management opportunities through partners, new customer acquisitions and expanding our existing customer base” said Eytan Bar, CEO of MTS.
“As we previously announced, we extended our largest existing MVNO services contract, with minimum revenues of $3.6 million during 2013. In addition, following last quarter’s announcement that we signed a new managed service agreement, we recently were able to successfully launch our MVNE service with this new MVNO in the US. The Company sees other opportunities in this market and we are working diligently to turn them into new contracts. We are looking forward to improving both our top and bottom line performance,” concluded Mr. Bar.
Financial highlights include:
• Revenues for the third quarter of 2012 increased to $3.4 million, compared with $3.0 million in revenues during the same quarter last year and revenues of $3.3 million in the second quarter of 2012. For the nine months period ended September 30, 2012, revenues were $9.6 million, compared with $8.8 million versus prior year.
• Operating profit was $692,000 in the third quarter of 2012 compared to a $244,000 for the third quarter of 2011 and $517,000 in the second quarter of 2012. It was $1.5 million for the nine months period ended September 30, 2012, compared to an operating profit of $439,000 for the same period last year.
• Net Income, on a non-GAAP basis, excluding the non-recurring tax charge related to a court ruling, was $691,000 or $0.15 per diluted share for the third quarter, versus net income of $226,000, or $0.05 per diluted share, in the third quarter of 2011 and $460,000, or $0.10 per diluted share, in the second quarter of 2012. For the nine months ended September 30, 2012, it was $1.5 million, or $0.32 per diluted share, compared with net income of $588,000, or $0.13 per diluted share, in the comparable period of 2011.
• Net income for the third quarter, after a $446,000 non-recurring tax charge, was $245,000, or $0.05 per diluted share, compared with net income of $226,000, or $0.05 per diluted share, in the third quarter of 2011 and $460,000, or $0.10 per diluted share, in the second quarter of 2012. Net income for the nine months ended September 30, 2012 was $1.0 million, or $0.22 per diluted share, compared with net income of $588,000, or $0.13 per diluted share, in the comparable period in 2011. It was also negatively affected by a non-recurring tax charge of approximately $446,000, as a result of a court ruling relating to the Company’s appeal of a tax ruling of the Israeli tax authorities that was issued with respect to the 1997 to 1999 period. The company has not as yet received an assessment from the tax authorities.
• Cash and marketable securities were $4.6 million as compared to $3.4 million as at December 31, 2011. During the nine month period ended September 30, 2012 the company had positive operating cash flow of $1.3 million, as compared to positive operating cash flow of $800,000 during the nine month period ended September 30, 2011.
Mer Telemanagement Solutions, headquartered in Israel, is a worldwide provider of innovative products and services for comprehensive telecom expense management and enterprise mobility management solutions used by enterprises, telecommunication service providers, and mobile virtual network operators. For more information, visit www.mtsint.com
BioMedical Technology Solutions, a wholly owned subsidiary of BioMedical Technology Solutions Holdings, is a provider of innovative solutions for environmentally friendly biomedical waste disposal. Headquartered in Englewood, Colo., the company is dedicated to continually improving and refining its patented technologies in support of customers’ needs as well as compliance issues.
In addition to being committed to providing optimal economic and environmentally sound solutions to biomedical waste management, BMTS is actively engaged in educational efforts. The company is dedicated to developing a novel waste reclamation program in support of a safer, healthier environment.
BMTS sells and leases the patented Demolizer II System, which is the green alternative to biomedical waste disposal. Serving medical, dental, and veterinary offices; nursing homes; assisted living facilities; and other healthcare establishments, BMTS offers biomedical waste treatment solutions that are safer and more environmentally sound.
Developed in 1993 by Thermal Waste Technologies, Inc., the original patented Demolizer biomedical waste processing system has successfully completed more than 300,000 processes. BMTS acquired the Demolizer technology in 2005 and enhanced the system with advanced quality control, hardware, and remote diagnostics. The company then introduced the Demolizer II, a reconfigured and improved version, in 2006.
BMTS is continually developing technology and programs that make medical facilities safer, cleaner, and environmentally sound, offering solutions that help medical professionals run more efficient practices. The company’s technology is designed to save customers money as well as provide safer medical facilities. With just a button push, customers can process their biomedical sharps and red bag waste onsite – securely eliminating their cradle-to-grave liability. Because waste has been made sterile and sharps unrecognizable, the processed collector can then be tossed into an ordinary trash receptacle.
For more information, visit www.bmtscorp.com
Greenland Minerals and Energy is focused on the exploration and development of mineral resources in south Greenland. The company has been working on delivering a world class production center for specialty metals there since 2007. The Kvanefjeld site on Greenland’s southwest tip, part of the Ilimaussaq intrusive complex, is owned by the company. Having a substantial evaluation history, the site is considered by many to hold the world’s second largest deposit of rare earth oxides, in addition to containing substantial resources of uranium and zinc.
Greenland itself is highly prospective, but largely underexplored. Though it has a small population, just over 50,000 permanent residents, it is autonomous, maintaining only limited ties to Denmark, and is increasingly mining friendly. In 2009, Greenland assumed self-determination with responsibility for self-government, an important step that sees Greenland assume 100% control of its natural resources, which had formerly been shared with Denmark.
Greenland is governed as a democracy by the Greenland Self Rule Government, and is recognized as an OECD member. The government there recognizes that the responsible development of mineral resources is critical to the future economy of Greenland. Greenland is looking to mineral and hydrocarbon resources to replace the waning fishing industry in the years to come. In addition, the Danish government is looking to reduce its financial subsidy of Greenland, and the development of resource projects provides the best path.
Kvanefjeld is today recognized as one of the most substantial mineral resources of its kind globally. With the recent discovery of three satellite deposits, the overall resource base of the northern Ilimaussaq complex will continue to grow for many years. In short, Greenland Minerals and Energy is now firmly placed to become one of the world’s largest and most cost-effective producers of specialty metals.
For additional information on the case, visit www.GGG.gl
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Cardium Therapeutics, Inc. (CXM) Announces the Acquisition of To Go Brands
- Consorteum Holdings, Inc. (CSRH) Subsidiary, Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming with the Acquisition of To Go Brands
- GlobalWise Investments, Inc. (GWIV) Teams Up With MWA Intelligence to Participate in Two Imaging Channel Conferences
- GreeneStone Healthcare Corp. (GRST) Seeks Amex Listing - New Report Confirms Demand
- International Stem Cell Corp. (ISCO) Lifeline Cell Technology Products to Be Added to Fisher Scientific's Catalogs
- Loans4Less.com, Inc. (LFLS) Provides Preliminary Financial Results for the Third Quarter of 2012
- Skinny Nutritional Corp. (SKNY) to Change the Way You Think About Your Water With the Introduction of Skinny Water pH+
- TNI BioTech Inc. (TNIB) and Hubei Qianjiang Pharmaceuticals Co., Ltd., Announce Venture Partnership for the Development of New Drug for Cancer Therapies
- VistaGen Therapeutics, Inc. (VSTA) Completes $3.25 Million Financing and $3.0 Million Debt Restructuring